David Dehler

David Dehler has a work experience spanning several companies and roles. David is currently the Executive Director of Preclinical Business Development at Xybion Digital since May 2022. Prior to this, they served as the Executive Director of Business Development at AIT Bioscience/Nexelis from October 2019 to April 2022. From September 2016 to October 2019, they worked as the Director of Business Development at AIT Bioscience. Before that, they were the Executive Director of Sales & Marketing at Smithers Avanza from September 2012 to September 2016. From May 2011 to August 2012, they held the position of Sr. Director of Business Development at QPS, LLC. David also worked as the Vice President of Business Development at Eurofins from June 2009 to May 2011, and as the Director of Business Development at Ricerca Biosciences from February 2008 to June 2009. Prior to that, they held the role of Sr. Director of Business Development at Bridge/Gene Logic Labs from April 2005 to March 2008. Their earliest known work experience is as the Manager of Sales & Marketing at Exygen Research, which occurred sometime in 2003.

David Dehler completed their Bachelor of Arts (B.A.) degree in Biology and Environmental Science from Purchase College, SUNY from 1980 to 1985. Subsequently, they pursued their studies in Toxicology at American University from 1990 to 1996.